The discovery of the role of the circCUL2/MyD88/NF-κb signaling pathway in activating and maintaining iCAFs in the TME may be needed for the development of rational strategies that selectively target tumor-promoting CAFs in PDAC. The gene discussed is MYD88; the disease is neoplasm.